Trial Profile
A double-blind, placebo and active controlled, single and multiple rising dose, safety, tolerance, and pharmacokinetic study of TR-701 [DA-70218] in normal healthy adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Dec 2023
Price :
$35
*
At a glance
- Drugs Tedizolid (Primary) ; Linezolid
- Indications Gram-positive infections; Nosocomial pneumonia; Pneumonia; Skin and soft tissue infections; Ventilator associated pneumonia
- Focus Adverse reactions
- Acronyms SAD/MAD
- Sponsors Trius Therapeutics
- 15 Nov 2016 Results of this and one other phase 1 study assessing ophthalmologic and neurologic clinical examinations published in the American Journal of Therapeutics
- 17 Jun 2016 Results of a retrospective analysis (n=40) published in the Journal of Antimicrobial Chemotherapy
- 07 Aug 2013 Results published in Pharmacotherapy.